SCHEMBL6593149

SCHEMBL6593149

COCCN(C)S(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C)n2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 19/20 1.00
CDK4 P11802 7/20 0.71
CDK1 P06493 2/20 0.51
KCNH2 Q12809 2/20 0.51
CCNT1 O60563 1/20 0.51
CCNB1 P14635 1/20 0.51
CSNK2A2 P19784 1/20 0.51
CCNA2 P20248 1/20 0.51
CCND1 P24385 1/20 0.51
CCNE1 P24864 1/20 0.51
CCND3 P30281 1/20 0.51
MAPK8 P45983 1/20 0.51
MAPK9 P45984 1/20 0.51
CSNK1A1 P48729 1/20 0.51
CSNK1D P48730 1/20 0.51
GSK3A P49840 1/20 0.51
GSK3B P49841 1/20 0.51
CDK7 P50613 1/20 0.51
CDK9 P50750 1/20 0.51
CCNH P51946 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27533851 0.89 CDK2 (0.81) CDK2CDK4CDK1KCNH2CCNT1
SCHEMBL4818566 0.83 CDK2 (1.00) CDK2CDK4CDK1
SCHEMBL6598372 0.83 CDK2 (0.77) CDK2CDK4CDK1KCNH2CCNT1
SCHEMBL6593918 0.82 CDK2 (0.90) CDK2CDK4CDK1KCNH2CCNT1
SCHEMBL5105293 0.81 CDK2 (0.77) CDK2CDK4CDK1KCNH2CCNT1
SCHEMBL6103727 0.80 CDK2 (0.81) CDK2CDK4CDK1KCNH2CCNT1
SCHEMBL6595895 0.80 CDK2 (0.81) CDK2CDK4CDK1KCNH2CCNT1
SCHEMBL6595042 0.80 CDK2 (0.66) CDK2CDK4CDK1KCNH2CCNT1
SCHEMBL6296195 0.80 CDK2 (0.66) CDK2CDK4CDK1KCNH2CCNT1
SCHEMBL6594277 0.80 CDK2 (0.66) CDK2CDK4CDK1KCNH2CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1351958-B1 IMIDAZOLO-5-YL-2-ANILINO-PYRIMIDINES AS AGENTS FOR THE INHIBITION OF THE CELL PROLIFERATION ASTRAZENECA AB (SE) 2004-06-16 EP disclosed